Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from CVS

S&P 500: Palantir, 2024's Big Winner, Leads Again In 2025. These Giants Are Laggards.

Palantir is leading the S&P 500 in 2025 after dominating last year. Megacaps such as Apple and Tesla are laggards.

Investors Business Daily

Rite Aids could be closing down as company eyes second bankruptcy in two years

Rite Aids could be closing down as company eyes second bankruptcy in two years

The troubled drugstore chain previously filed for Chapter 11 bankruptcy in 2023, which resulted in more than 800 store closures

The Independent UK

CVS Health Earnings Preview: What to Expect

CVS Health Earnings Preview: What to Expect

CVS Health is scheduled to report its first-quarter results next month, and analysts expect a double-digit earnings growth.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Walgreens to pay up to $350 million in U.S. opioid settlement

Walgreens has agreed to pay up to $350 million in a settlement with the U.S. Department of Justice, who accused the pharmacy of illegally filling millions of prescriptions in the last decade for opioids and other controlled substances

The Independent UK

2 Healthcare Recession-Resistant Stocks Unaffected by Tariffs

Health insurance stocks are outperforming the benchmark indices in 2025, as these two tariff-free and recession-resistant carriers are up 16% and 54%.

Top 3 S&P 500 Winners in a Losing Market

Despite a broad market correction in 2025, three S&P 500 stocks have defied the downturn, delivering standout performance and showcasing strong fundamentals.

Watch Your Brain Glitch Looking At These 22 Bizarre Discoveries

Buckle up, because we're about to dive into the section where product designers clearly said "reality is boring" and chose chaos instead.

inkl

Read news from The Economist, FT, and more,
with one subscription

Investors Can't Get Enough Of These 7 Trump-Proof Dividend Stocks

Investors Can't Get Enough Of These 7 Trump-Proof Dividend Stocks

Investors nervous about President Trump's tariffs have one thing on their mind: S&P 500 dividends.

Investors Business Daily

Watch Your Brain Glitch Looking At These 22 Bizarre Discoveries

Watch Your Brain Glitch Looking At These 22 Bizarre Discoveries

Buckle up, because we're about to dive into the section where product designers clearly said "reality is boring" and chose chaos instead. The post Watch Your Brain Glitch Looking At These 22 Bizarre Discoveries first appeared on Bored Panda.

4 Healthcare Stocks With Massive Gains—and More to Come

4 Healthcare Stocks With Massive Gains—and More to Come

Healthcare is the top industry of 2025 so far. These healthcare companies have seen 30% increases in share prices since the beginning of the year.

The 'menopause penalty': Many women in midlife see a drop in wages, new study finds

The 'menopause penalty': Many women in midlife see a drop in wages, new study finds

A new study asserts that women experience a drop in earnings at the end of their child-bearing years.

This 1 Unlikely Dividend Stock Is the Top S&P 500 Company in 2025. Should You Buy It Now?

This 1 Unlikely Dividend Stock Is the Top S&P 500 Company in 2025. Should You Buy It Now?

As trade wars continue to rattle markets, this unexpected S&P 500 stock is defying the market turbulence and emerging as a winner in 2025.

These Are the 3 Top-Performing Dividend Stocks So Far in 2025

These Are the 3 Top-Performing Dividend Stocks So Far in 2025

Despite recent market volatility, select dividend stocks thrive, offering yield, growth, and stability.

These 3 Dividend Stocks Jumped 15% in a Month—More to Come?

These 3 Dividend Stocks Jumped 15% in a Month—More to Come?

Dividend stocks aren't just for long-term income generation. These three shares have jumped 15% in one month while also offering dividend payouts.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

CVS is opening more standalone pharmacies after shuttering 1,000 stores

CVS will open a dozen new stores, but they’ll be half the size of a typical location

The Guardian - US

Texas cities run short of MMR vaccine as measles outbreak drives demand

Pharmacies are struggling with supplies as fatal outbreak expands and health secretary sows disinformation

3 Dividend Stocks To Buy and Survive a Market Crash

Defensive sectors like consumer staples, healthcare, and utilities offer stability during downturns. Three top-rated picks were identified for their resilience, high yields, and growth potential.

Is CVS Health Stock Outperforming the S&P 500?

CVS Health has outperformed the broader S&P Index’s performance over the past year, and analysts remain strongly upbeat about the stock’s prospects.

Get all your
news in one place.

100’s of premium titles.
One news app.

93 Receipts That Prove You Should Always Check The Fine Print (New Pics)

On an average day, there’s not much about receipts that’s particularly exciting. But sometimes, if you check the fine print, you’ll find more than just numbers. The post 93 Receipts That Prove You Should Always Check The Fine Print (New Pics) first appeared on Bored Panda.

3 Beaten Down Healthcare Stocks Recovering in 2025

Healthcare stocks took a tumble in 2024 as rising medical costs did a number on margins and profitability, but 2025 may be the year they rebound.

This Dividend Stock Is Up 45% in 2025. Is It Too Late to Buy Shares Now?

CVS stock has surged 45% in 2025, driven by strong Q4 earnings, a new CEO, and strategic innovations.

CVS Health: Earnings Beat Ignites Stock Rally

CVS Health's stock is showing upward movement after exceeding quarterly earnings expectations, suggesting a potential positive shift.

Investors Business Daily

CVS Health Clears Low Earnings Bar, Leads S&P 500 On Return To Growth In '25

CVS Health earnings topped estimates and the company expects 2025 to be a turnaround year.

S&P Futures Tick Lower With Focus on U.S. Inflation Data and Powell’s Testimony

March S&P 500 E-Mini futures (ESH25) are trending down -0.12% this morning as investors braced for the release of key U.S. inflation data while also awaiting further testimony from Federal Reserve Chair Jerome Powell.

Inflation Still a Concern: January CPI Data Exceeds Forecasts

March S&P 500 E-Mini futures (ESH25) are trending down -1.08% this morning as January's CPI data exceeded expectations, while also awaiting further testimony from Federal Reserve Chair Jerome Powell.

People

109,963 stories

Robert F. Kennedy Jr

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

264,519 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play